Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunopathology of rheumatoid arthritis.
Pablos JL, Cañete JD. Pablos JL, et al. Curr Top Med Chem. 2013;13(6):705-11. doi: 10.2174/1568026611313060003. Curr Top Med Chem. 2013. PMID: 23574519 Review.
Differential Antigen-presenting B Cell Phenotypes from Synovial Microenvironment of Patients with Rheumatoid and Psoriatic Arthritis.
Armas-González E, Díaz-Martín A, Domínguez-Luis MJ, Arce-Franco MT, Herrera-García A, Hernández-Hernández MV, Bustabad S, Usategui A, Pablos JL, Cañete JD, Díaz-González F. Armas-González E, et al. Among authors: pablos jl. J Rheumatol. 2015 Oct;42(10):1825-34. doi: 10.3899/jrheum.141577. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178284
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
Acebes C, Andreu JL, Balsa A, Batlle E, de Toro-Santos J, García Llorente F, Hernández MV, Fernández-Gutiérrez B, Hidalgo-Calleja C, Mayordomo L, Naredo E, Narváez FJ, Ortiz AM, Pablos JL, Pérez-Sandoval T, Rodríguez-Lozano C, Sánchez-Pernaute O, Usón J, Negrón JB, Loza E, Carmona L, Gómez Castro S, Montoro Alvarez M. Acebes C, et al. Among authors: pablos jl. Clin Exp Rheumatol. 2017 Sep-Oct;35(5):816-822. Epub 2017 May 8. Clin Exp Rheumatol. 2017. PMID: 28516881
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
Cohen S, Genovese MC, Choy E, Perez-Ruiz F, Matsumoto A, Pavelka K, Pablos JL, Rizzo W, Hrycaj P, Zhang N, Shergy W, Kaur P. Cohen S, et al. Among authors: pablos jl. Ann Rheum Dis. 2017 Oct;76(10):1679-1687. doi: 10.1136/annrheumdis-2016-210459. Epub 2017 Jun 5. Ann Rheum Dis. 2017. PMID: 28584187 Free PMC article. Clinical Trial.
176 results